Universe Pharmaceuticals Inc
4 hedge funds and large institutions have $794K invested in Universe Pharmaceuticals Inc in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
426% more capital invested
Capital invested by funds: $151K → $794K (+$643K)
300% more funds holding
Funds holding: 1 → 4 (+3)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
+$680K |
| 2 |
Walleye Capital
New York
|
+$55.2K |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$27.6K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PVI
1
Pura Vida Investments
New York
| $662K | +$680K | +74 | New |
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| $99K | – | – | – |
|
|
RJA
3
Raymond James & Associates
St Petersburg,
Florida
| $30K | +$27.6K | +3 | New |
|
4
UBS Group
Zurich,
Switzerland
| $3K | – | – | – |
|
|
5
Walleye Capital
New York
| $50 | +$55.2K | +6 | New |
|
UPC Hedge Fund Activity: Q3 2021 in Review
4 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q3 2021, worth a combined $794K — up 426% from $151K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new UPC positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Pura Vida Investments, opening a new position worth an estimated $680K.
- 4 institutional investors held Universe Pharmaceuticals Inc (UPC) as of Q3 2021, up from 1 in Q2 2021.
- Funds reported $794K of Universe Pharmaceuticals Inc stock for Q3 2021, up 426% quarter-over-quarter.
- 3 funds opened new Universe Pharmaceuticals Inc positions in Q3 2021 and 0 closed out, a net change of +3 holders.
- The largest Universe Pharmaceuticals Inc buyer in Q3 2021 was Pura Vida Investments, an estimated $680K added.
Based on aggregated 13F filings for Q3 2021.